drugset / Trial / NCT03580473

Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification

NCT03580473 ↗

Phase 2 Completed 118 enrolled EMS
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of Saturno II association on the control of ocular inflammation post-phacoemulsification

Timeline

Start
2020-02-27
Primary completion
2021-11-30
Completion
2022-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SATURNO II association Unknown — Other
Comparator Vigadexa Unknown — Other

Indications